University of Alabama Birmingham is a clinical research site located in Birmingham, Alabama, United States 32594.
Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.
University of Alabama Birmingham has participated in 141 clinical trials with 46 currently active.
Therapeutic areas: Breast Cancer, Niemann-Pick Disease, Type C, Multiple Myeloma.
Sponsors: Eli Lilly and Company, ZevraDenmark, Janssen Research & Development, LLC.
Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Alabama Birmingham has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Alabama Birmingham has 141 clinical trials on record, with 46 currently active. Their work covers Breast Cancer, Niemann-Pick Disease, Type C, Multiple Myeloma.
University of Alabama Birmingham has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.